Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism

Amber Hogart, Janine M LaSalle

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

GABA is the major inhibitory neurotransmitter in the mammalian brain and defects in inhibition have been implicated in autism spectrum disorders. GABA inhibition is mediated through a variety of receptor subunit genes. Three GABAA receptor subunit genes, GABRB3, GABRA5, and GABRG3 are located on chromosome 15q11-13. In addition to GABAA receptor subunit genes, chromosome 15q11-13 contains genes that are expressed based on the parental origin of the chromosome, a process termed genomic imprinting. Due to imprinting, deletions of chromosome 15q11-13 result in two different disorders, Prader-Willi syndrome and Angleman syndrome, depending on the parental origin of the deletion. Additionally maternal duplications of this genomic region are observed in 1-3% of autism cases. Although each of these disorders is clinically distinct, there are similarities in phenotypes, such as seizures, that may be due to improper levels of GABAA receptor genes. Genetic studies of families with autism without a known genetic cause have found evidence that genetic markers in GABRB3 are significantly associated with autism. Although genetic mutations have not been found in GABRB3, significantly reduced levels of GABRB3 protein were found in a majority of autism brain samples. Further studies have shown an abnormal expression pattern of only one parental copy of 15q11-13 GABAA receptor genes in a subset of autism samples. Since no evidence was found for a direct genetic explanation for this abnormal gene expression, we hypothesize that epigenetic changes, heritable modifications to DNA and the proteins that are involved in DNA packaging, may explain the expression abnormalities in autistic brain samples.

Original languageEnglish (US)
Title of host publicationThe Neurochemical Basis of Autism: From Molecules to Minicolumns
PublisherSpringer US
Pages113-127
Number of pages15
ISBN (Print)9781441912725, 9781441912718
DOIs
StatePublished - 2010

Fingerprint

GABA-A Receptors
Autistic Disorder
Epigenomics
Chromosomes, Human, Pair 13
Genes
gamma-Aminobutyric Acid
Brain
DNA Packaging
Genomic Imprinting
Prader-Willi Syndrome
Genetic Markers
Neurotransmitter Agents
Seizures
Proteins
Chromosomes
Mothers
Phenotype
Gene Expression
Mutation
DNA

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Hogart, A., & LaSalle, J. M. (2010). Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism. In The Neurochemical Basis of Autism: From Molecules to Minicolumns (pp. 113-127). Springer US. https://doi.org/10.1007/978-1-4419-1272-5_8

Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism. / Hogart, Amber; LaSalle, Janine M.

The Neurochemical Basis of Autism: From Molecules to Minicolumns. Springer US, 2010. p. 113-127.

Research output: Chapter in Book/Report/Conference proceedingChapter

Hogart, A & LaSalle, JM 2010, Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism. in The Neurochemical Basis of Autism: From Molecules to Minicolumns. Springer US, pp. 113-127. https://doi.org/10.1007/978-1-4419-1272-5_8
Hogart A, LaSalle JM. Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism. In The Neurochemical Basis of Autism: From Molecules to Minicolumns. Springer US. 2010. p. 113-127 https://doi.org/10.1007/978-1-4419-1272-5_8
Hogart, Amber ; LaSalle, Janine M. / Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism. The Neurochemical Basis of Autism: From Molecules to Minicolumns. Springer US, 2010. pp. 113-127
@inbook{c23b18830ffd435aa139a98b939fcd6e,
title = "Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism",
abstract = "GABA is the major inhibitory neurotransmitter in the mammalian brain and defects in inhibition have been implicated in autism spectrum disorders. GABA inhibition is mediated through a variety of receptor subunit genes. Three GABAA receptor subunit genes, GABRB3, GABRA5, and GABRG3 are located on chromosome 15q11-13. In addition to GABAA receptor subunit genes, chromosome 15q11-13 contains genes that are expressed based on the parental origin of the chromosome, a process termed genomic imprinting. Due to imprinting, deletions of chromosome 15q11-13 result in two different disorders, Prader-Willi syndrome and Angleman syndrome, depending on the parental origin of the deletion. Additionally maternal duplications of this genomic region are observed in 1-3{\%} of autism cases. Although each of these disorders is clinically distinct, there are similarities in phenotypes, such as seizures, that may be due to improper levels of GABAA receptor genes. Genetic studies of families with autism without a known genetic cause have found evidence that genetic markers in GABRB3 are significantly associated with autism. Although genetic mutations have not been found in GABRB3, significantly reduced levels of GABRB3 protein were found in a majority of autism brain samples. Further studies have shown an abnormal expression pattern of only one parental copy of 15q11-13 GABAA receptor genes in a subset of autism samples. Since no evidence was found for a direct genetic explanation for this abnormal gene expression, we hypothesize that epigenetic changes, heritable modifications to DNA and the proteins that are involved in DNA packaging, may explain the expression abnormalities in autistic brain samples.",
author = "Amber Hogart and LaSalle, {Janine M}",
year = "2010",
doi = "10.1007/978-1-4419-1272-5_8",
language = "English (US)",
isbn = "9781441912725",
pages = "113--127",
booktitle = "The Neurochemical Basis of Autism: From Molecules to Minicolumns",
publisher = "Springer US",

}

TY - CHAP

T1 - Epigenetic dysregulation of 15q11-13 GABAA receptor genes in autism

AU - Hogart, Amber

AU - LaSalle, Janine M

PY - 2010

Y1 - 2010

N2 - GABA is the major inhibitory neurotransmitter in the mammalian brain and defects in inhibition have been implicated in autism spectrum disorders. GABA inhibition is mediated through a variety of receptor subunit genes. Three GABAA receptor subunit genes, GABRB3, GABRA5, and GABRG3 are located on chromosome 15q11-13. In addition to GABAA receptor subunit genes, chromosome 15q11-13 contains genes that are expressed based on the parental origin of the chromosome, a process termed genomic imprinting. Due to imprinting, deletions of chromosome 15q11-13 result in two different disorders, Prader-Willi syndrome and Angleman syndrome, depending on the parental origin of the deletion. Additionally maternal duplications of this genomic region are observed in 1-3% of autism cases. Although each of these disorders is clinically distinct, there are similarities in phenotypes, such as seizures, that may be due to improper levels of GABAA receptor genes. Genetic studies of families with autism without a known genetic cause have found evidence that genetic markers in GABRB3 are significantly associated with autism. Although genetic mutations have not been found in GABRB3, significantly reduced levels of GABRB3 protein were found in a majority of autism brain samples. Further studies have shown an abnormal expression pattern of only one parental copy of 15q11-13 GABAA receptor genes in a subset of autism samples. Since no evidence was found for a direct genetic explanation for this abnormal gene expression, we hypothesize that epigenetic changes, heritable modifications to DNA and the proteins that are involved in DNA packaging, may explain the expression abnormalities in autistic brain samples.

AB - GABA is the major inhibitory neurotransmitter in the mammalian brain and defects in inhibition have been implicated in autism spectrum disorders. GABA inhibition is mediated through a variety of receptor subunit genes. Three GABAA receptor subunit genes, GABRB3, GABRA5, and GABRG3 are located on chromosome 15q11-13. In addition to GABAA receptor subunit genes, chromosome 15q11-13 contains genes that are expressed based on the parental origin of the chromosome, a process termed genomic imprinting. Due to imprinting, deletions of chromosome 15q11-13 result in two different disorders, Prader-Willi syndrome and Angleman syndrome, depending on the parental origin of the deletion. Additionally maternal duplications of this genomic region are observed in 1-3% of autism cases. Although each of these disorders is clinically distinct, there are similarities in phenotypes, such as seizures, that may be due to improper levels of GABAA receptor genes. Genetic studies of families with autism without a known genetic cause have found evidence that genetic markers in GABRB3 are significantly associated with autism. Although genetic mutations have not been found in GABRB3, significantly reduced levels of GABRB3 protein were found in a majority of autism brain samples. Further studies have shown an abnormal expression pattern of only one parental copy of 15q11-13 GABAA receptor genes in a subset of autism samples. Since no evidence was found for a direct genetic explanation for this abnormal gene expression, we hypothesize that epigenetic changes, heritable modifications to DNA and the proteins that are involved in DNA packaging, may explain the expression abnormalities in autistic brain samples.

UR - http://www.scopus.com/inward/record.url?scp=80052740445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052740445&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1272-5_8

DO - 10.1007/978-1-4419-1272-5_8

M3 - Chapter

AN - SCOPUS:80052740445

SN - 9781441912725

SN - 9781441912718

SP - 113

EP - 127

BT - The Neurochemical Basis of Autism: From Molecules to Minicolumns

PB - Springer US

ER -